Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V I Kurmashov

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Voprosy Onkologii|January 1, 1997
[Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol]A V Popa, S A Maiakova, V I Kurmashov
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Clinical effect and some pathogenic mechanisms of high dose monomeric IgG therapy in childhood chronic idiopathic thrombocytopenic purpuraI V Koshel, N A Torubarova, K O Omarova, et al.
Antibiotiki|September 1, 1980
[L-asparaginase study results (phase II of the clinical trials)]N A Kondrat'eva, G V Kruglova, Iu I Lorie, et al.
Pediatriia|January 1, 1989
[Pathogenesis of immunologic deficiency in the initial stage of lymphogranulomatosis in children]N A Torubarova, V I Kurmashov, L V Dolotova, et al.
Voprosy Virusologii|July 1, 1995
[Humoral antiviral immunity in children with hematologic neoplasms]L L Nisevich, K N Abaĭyldanova, S G Kosideeva, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 16, 2000
[Specific features of stem cell (CD34+) subvariant of acute lymphoblast cell leukemia in children]S A Maiakova, N N Tupitsyn, N V Gavrikova, et al.
Voprosy Onkologii|January 1, 1997
[Changes of lipid peroxidation parameters in children being treated for cancer]G V Kazanova, V N Baĭkova, K O Dumbraĭs, et al.
Voprosy Onkologii|January 1, 1997
[Cardioxane in pediatric oncohematology]V I Kurmashov, I E Gavrilova, S A Maiakova, et al.
Gematologiia I Transfuziologiia|September 1, 1989
[Late (after 5-year remission) recurrences of acute leukemia in children (a cooperative study)]N S Kisliak, L A Makhonova, I V Koshel', et al.
Advances in Experimental Medicine and Biology|September 29, 1999
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patientsBaryshnikov AYu, E R Polosukhina, N N Tupitsin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Voprosy Onkologii|January 1, 1997
[Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol]A V Popa, S A Maiakova, V I Kurmashov
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Clinical effect and some pathogenic mechanisms of high dose monomeric IgG therapy in childhood chronic idiopathic thrombocytopenic purpuraI V Koshel, N A Torubarova, K O Omarova, et al.
Antibiotiki|September 1, 1980
[L-asparaginase study results (phase II of the clinical trials)]N A Kondrat'eva, G V Kruglova, Iu I Lorie, et al.
Pediatriia|January 1, 1989
[Pathogenesis of immunologic deficiency in the initial stage of lymphogranulomatosis in children]N A Torubarova, V I Kurmashov, L V Dolotova, et al.
Voprosy Virusologii|July 1, 1995
[Humoral antiviral immunity in children with hematologic neoplasms]L L Nisevich, K N Abaĭyldanova, S G Kosideeva, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|August 16, 2000
[Specific features of stem cell (CD34+) subvariant of acute lymphoblast cell leukemia in children]S A Maiakova, N N Tupitsyn, N V Gavrikova, et al.
Voprosy Onkologii|January 1, 1997
[Changes of lipid peroxidation parameters in children being treated for cancer]G V Kazanova, V N Baĭkova, K O Dumbraĭs, et al.
Voprosy Onkologii|January 1, 1997
[Cardioxane in pediatric oncohematology]V I Kurmashov, I E Gavrilova, S A Maiakova, et al.
Gematologiia I Transfuziologiia|September 1, 1989
[Late (after 5-year remission) recurrences of acute leukemia in children (a cooperative study)]N S Kisliak, L A Makhonova, I V Koshel', et al.
Advances in Experimental Medicine and Biology|September 29, 1999
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patientsBaryshnikov AYu, E R Polosukhina, N N Tupitsin, et al.
Pageof 1